AdminJan 30, 20222 minRibbon Biolabs Raises EUR 18 Million Series A Financing for DNA Synthesis TechnologyVIENNA, AUSTRIA, January 31, 2022 -- Ribbon Biolabs, the DNA synthesis company, today announced the successful close of EUR 18 million in...
AdminJul 12, 20212 minHelicase Venture portfolio company Absci files for IPOhttps://seekingalpha.com/news/3711566-biotech-discovery-company-absci-files-for-ipo Absci Corp., a synthetic biology company whose...